Immunological biomarkers predict HIV-1 viral rebound after treatment interruption - Wikidata - wikimedia - TriplyDB

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

http://www.wikidata.org/entity/Q36250043

about

Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research Immune activation and paediatric HIV-1 disease outcome HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells.Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle Sanctuary CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection International AIDS Society global scientific strategy: towards an HIV cure 2016.Curing HIV: Moving Forward Faster.Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.Paediatric HIV infection: the potential for cure.Kill: boosting HIV-specific immune responses.Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection.Divergent Expression of CXCR5 and CCR5 on CD4+ T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection.Barriers to HIV remission research in low- and middle-income countries.Treatment interruption after 2-year antiretroviral treatment initiated during acute/early HIV in infancy.The investigation of CD4+T-cell functions in primary HIV infection with antiretroviral therapy.HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.Immune checkpoints and the HIV-1 reservoir: proceed with caution.Highlights from the Conference on Retroviruses and Opportunistic Infections 2016: 22-25 February 2016, Boston, Massachusetts, USA.Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission?Immune checkpoint blockade in infectious diseases.Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.Immune Checkpoint Inhibitors in Melanoma and HIV Infection.Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment.Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption.Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs.Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In Situ.CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.CD3ε Expression Defines Functionally Distinct Subsets of Vδ1 T Cells in Patients With Human Immunodeficiency Virus Infection.Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency Targeting Immune Checkpoint Molecules to Eliminate Latent HIV

P2860

Q27312050-B15F4936-7A30-40EF-9833-CD47C889C562 Q28077662-02D5556A-159F-4BEB-8779-57A7A4D3258E Q28086888-976F308F-238F-4502-A06B-D7FE231D20BA Q33586177-11E696D6-DD8A-46DC-8EB0-F96F411E0AEE Q33742139-DDF4FD24-B872-4182-82DE-6240E8C2B34D Q36077348-21AB9D29-7269-4283-AE09-456633462ACA Q36077705-A48A38F5-1B6E-4E9E-BA77-0585347C48F4 Q36108518-960BB705-BE4D-4C66-9503-F1771A7C3902 Q36758540-2C2F4AD9-4CE0-4432-9FB9-CE0592E4A5C5 Q37003624-7702031E-FD62-4DF8-B36B-842C32E515B7 Q37661770-8428FE9D-4781-468A-AB26-1A330434A1E7 Q38581140-333F3CC8-F104-4063-8B17-5EE456584D43 Q38682297-CF45363D-CCC5-40BA-8EEB-DEA31D0DB82A Q38773102-9E4F1AA2-969F-436C-8BCA-6227DE10E860 Q38800533-60DCBD38-C947-48F0-9929-D5DC4A41C05E Q38855036-71551813-2B97-41D1-AD38-4B61CE9632A2 Q39335635-2AAC6230-077D-4F7D-AB5C-B5348CC6D10D Q39366791-D763FF24-BCBE-43B9-A296-A0A421EFBA1C Q39768190-6712E9C7-293B-4DDA-B401-4A8BC5E188DB Q40125887-F211E7F3-A515-43ED-9EEF-A10DB4B8D0AB Q40339502-5B0E3388-9610-4C6C-9512-A8A849B1E317 Q40591659-99A87B24-604D-4C99-A4CD-997DFA232C8C Q40591692-EF7DFF9D-3ABE-438F-A0F0-DD8B20D20E9E Q41918728-573501D3-BD7D-48A5-AC28-67E88592EA4B Q41921732-519068DF-EFD0-4B59-A2A4-BA1883CD6C98 Q41929341-5DE14AB2-7D91-4577-BDB6-244A3906782E Q47138765-245A5346-6118-438E-8DC1-F0BE68CE4B9F Q47307973-7CC911E0-2BC2-4016-B380-9BD18C6404BC Q47548478-8B15DF21-57DF-40D3-9DC4-3D86E4D0AF14 Q47553711-8A127A8C-550B-4752-B467-258701982502 Q48113493-37CEF7AC-292D-4E35-8FC1-4293A63BDFE9 Q49920984-2B1D7D11-3388-48B1-9E5F-7169ED11E4EE Q50026446-FDC4071F-AC9C-4F97-8CDE-F8556B278A8D Q54204987-1C6958B5-EC82-4EE2-A7B0-43077C16DD96 Q54209309-8D2732D0-27B1-40AC-938B-D479131CE0D9 Q56891188-3977DBCD-48FC-494D-A147-24BA6395C8C2 Q58003757-5756763A-6CF2-4940-B2F3-58345E8343DE Q59127701-D721BF3B-80D3-4870-96A2-C8D06DFACDC2

P2860

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

http://www.wikidata.org/entity/Q36250043

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

@ast

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

@en

type

label

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

@ast

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

@en

prefLabel

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

@ast

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

@en

P1433

Q36250043-181AFF93-189B-4885-8F65-5D5BBA706B3A

P1476

Q36250043-32D9C608-13D2-4A58-AC17-422297435147

P2093

Q36250043-02A6B4AB-E497-492B-AB9D-8478E0ED1DD1

Q36250043-03418A89-BEB3-4716-80D9-B90266F840DA

Q36250043-12E6FF27-6D0F-4B16-BAE6-4AD7EFBE7BC4

Q36250043-29DCA4B5-7FA9-487D-9F3E-1883976D197D

Q36250043-2C606A65-7037-4CAC-9923-CD74C0E7AF47

Q36250043-2F56E881-0C86-44DA-872D-3DE87D951260

Q36250043-36384A6F-2792-4503-98E9-2D5FCA64285C

Q36250043-3AB45F1D-7318-4ECD-B35F-88FAEDCD9C1D

Q36250043-42BE873F-298C-4F1D-A5C2-5F70730DE95B

Q36250043-47FCAA0C-C95D-4B8C-9687-09231CDA65CB

P2860

Q36250043-0492C677-67C7-4F3C-B062-10B92BD11C07

Q36250043-063214B3-DA47-4975-A804-E893317F60A3

Q36250043-0BA65025-003F-456E-97B1-7FDD491E84AE

Q36250043-12122963-638F-416A-91A7-E47B0FC58BB1

Q36250043-24C054A2-EDEE-4E78-8041-FC0CAC615F86

Q36250043-2AE1ACA8-038C-4BAA-A9FF-E709E3AC06EC

Q36250043-3C17A13C-E042-4001-B5D6-593CB6BBC2CD

Q36250043-43EBF875-F361-49E2-BAE2-0D118DE250A9

Q36250043-4A03692D-E852-4446-B72B-ABD83849F0DA

Q36250043-5888B84A-1D6E-435B-A230-3AC43FF24BAF

P2888

Q36250043-1AAA5A2A-B500-4628-BBCD-42C3FC1FE054

P304

Q36250043-16EC9A01-F293-4F7F-8CBD-AE5C4116D67F

P31

Q36250043-78E3D91A-A071-4A8E-9F52-9A79DD1CD983

P356

Q36250043-C4B3D47A-3A39-4453-8782-029309C5F6FB

P407

Q36250043-818A5F31-EC8A-4B8D-B6FC-83B8B9DC56E3

P478

Q36250043-E0D1DE65-C393-4D24-AD6C-A552BA83B9E7

P50

Q36250043-2407E054-5BB4-47AD-8925-4A9FE578E080

Q36250043-A0F33E51-B4FD-4C0C-8A48-19E97AD90D9B

Q36250043-AA492DD7-77C5-464A-8DD1-88B1B119AB0A

Q36250043-E2323953-9661-4D0D-85F4-5A5A35125278

Q36250043-E9547709-6B87-4568-8A7C-75DC6C40D874

P577

Q36250043-E19479BF-7E0B-4DDE-90F8-989D2EC80D13

P5875

Q36250043-65937426-B970-453F-84FA-1E16B2124581

P698

Q36250043-61D0A016-96FB-4943-8FB6-E4C12D15FCC4

P921

Q36250043-C23574C0-B4F8-4584-9610-E013E60AEB2F

P932

Q36250043-1113EDD9-8DA2-4243-8308-2F701A0DD9B6

P356

P1433

Nature Communications

P1476

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

@en

P2093

Abdel Babiker

http://www.w3.org/2001/XMLSchema#string

Anthony D Kelleher

http://www.w3.org/2001/XMLSchema#string

David A Cooper

http://www.w3.org/2001/XMLSchema#string

Elizabeth Hamlyn

http://www.w3.org/2001/XMLSchema#string

Giuseppe Tambussi

http://www.w3.org/2001/XMLSchema#string

Helen Brown

http://www.w3.org/2001/XMLSchema#string

Jacob Hurst

http://www.w3.org/2001/XMLSchema#string

James P Williams

http://www.w3.org/2001/XMLSchema#string

Jodi Meyerowitz

http://www.w3.org/2001/XMLSchema#string

Jonathan Weber

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients

Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

A whole-genome association study of major determinants for host control of HIV-1

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

CD4+ count-guided interruption of antiretroviral treatment

Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline, 'definetherain'

High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.

P2888

P304

8495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS9495

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Christian B Willberg

P577

2015-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283283565

http://www.w3.org/2001/XMLSchema#string

P698

26449164

http://www.w3.org/2001/XMLSchema#string

P921

P932

4633715

http://www.w3.org/2001/XMLSchema#string